EYE
NOVA EYE FPO [EYE]
Healthcare · ASX Small Cap
$0.1450 -3.3%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score +5First seen: 2026-02-25
Score Breakdown
Technical59
Catalyst52
Sentiment50
Fundamental68
Momentum70
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Price at lower Bollinger Band (oversold)
- Sustained volume spike (2.1x median) on DOWN trend
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Low cash runway (3 quarters) - dilution risk
- Low P/S ratio (1.5x)
- Strong revenue growth (+24%)
- EPS estimates revised upward (+10pts)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (18%)
- Strong 12-1 momentum (+52%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Negative 5-day momentum (-9.4%)
- Deeply negative margins (-31%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Investor Webinar Tuesday 3 March @11.30 AEDT
NONE EYE Delivers Sales Growth and Improves Bottom Line
NONE Half Yearly Report and Accounts
LOW Investor Presentation Half Year Results
Recent ASX Announcements
| 2026-02-25 | Investor Webinar Tuesday 3 March @11.30 AEDT |
| 2026-02-25 | Investor Presentation Half Year Results |
| 2026-02-25 | EYE Delivers Sales Growth and Improves Bottom Line PRICE SENSITIVE |
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-11 | Re-lodgement of Appendix 4G |
Key Metrics
$42.7M
Market Cap
365K
Avg Volume
2.1x
Vol Ratio
$0.09 — $0.20
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-45.0%
ROE
-31.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 82% |
| L | Leader vs Laggard | pass | RS: 2 |
| I | Institutional Sponsorship | pass | Inst: 18% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #16 of 119 · Sector avg: 51
View all Healthcare signals →